Author： Chey William D Cash Brooks D
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.14, Iss.2, 2005-02, pp. : 185-193
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Serotonergic modulation and irritable bowel syndrome
By Borman R.
Expert Opinion on Emerging Drugs, Vol. 6, Iss. 1, 2001-04 ,pp. :
Access to resources
Recommend
Inpharma, Vol. 1, Iss. 1590, 2007-01 ,pp. :
New Drugs in the Management of the Irritable Bowel Syndrome
Drugs, Vol. 56, Iss. 1, 1998-07 ,pp. :
Alosetron and irritable bowel syndrome
By Mayer Emeran A Bradesi Sylvie
Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 11, 2003-11 ,pp. :